サマリー

ブデソニド吸入剤は、喘息を含む様々な呼吸器系疾患の治療に使用されるコルチコステロイド剤です。コルチコステロイドは、気道の腫れや炎症を抑え、肺の空気の流れを良くする働きがあります。

市場分析と洞察。日本および世界のブデソニド吸入剤市場
本レポートでは、世界と日本のBudesonide Inhaler市場に焦点を当てています。
2020年のBudesonide Inhalerの世界市場規模は4486.5百万米ドルで、2021-2027年の間に3.3%のCAGRで、2027年末には5801.7百万米ドルに達すると予想されています。日本では、Budesonide Inhalerの市場規模は、2020年のXX百万米ドルから2027年にはXX百万米ドルまで、予測期間中にXX％のCAGRで成長すると予想されています。

世界のBudesonide Inhalerの範囲と市場規模
Budesonide Inhaler市場は、地域（国）別、プレイヤー別、タイプ別、アプリケーション別に分類されています。世界のBudesonide Inhaler市場に参加するプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、地域（国）別、タイプ別、アプリケーション別に、2016年から2027年までの収益と予測に焦点を当てています。
日本市場については、2016-2027年のBudesonide Inhalerの市場規模を、プレイヤー別、タイプ別、アプリケーション別に分析しています。主要プレイヤーには、日本で重要な役割を果たしているグローバルプレイヤーとローカルプレイヤーが含まれています。

タイプ別セグメント
ドライパウダー
サスペンション
スプレー

用途別セグメント
病院薬剤師
小売薬局
オンライン薬局

地域別
北アメリカ
U.S.
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジアパシフィック
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中近東・アフリカ
トルコ
サウジアラビア
U.A.E.

会社別
アストラゼネカ
コスモファーマシューティカルズ
テバ社
ノバルティス
マイラン
ファイザー
Dr.ファルク・ファーマ
Chiesi Farmaceutici
オリオン株式会社
シプラ社
バウシュ・ヘルス社
武田薬品工業
ルパン株式会社
Synmosa Biopharma Corporation
ルナン・ベター・ファーマシューティカル
上海サイン・ファーマシューティカル・ラボラトリーズ

ページTOPに戻る

目次

1 Study Coverage
1.1 Budesonide Inhaler Product Introduction
1.2 Market by Type
1.2.1 Global Budesonide Inhaler Market Size Growth Rate by Type
1.2.2 Dry Powder
1.2.3 Suspension
1.2.4 Sprays
1.3 Market by Application
1.3.1 Global Budesonide Inhaler Market Size Growth Rate by Application
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Budesonide Inhaler Market Size, Estimates and Forecasts
2.1.1 Global Budesonide Inhaler Revenue 2016-2027
2.1.2 Global Budesonide Inhaler Sales 2016-2027
2.2 Global Budesonide Inhaler, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Budesonide Inhaler Historical Market Size by Region (2016-2021)
2.3.1 Global Budesonide Inhaler Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Budesonide Inhaler Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Budesonide Inhaler Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Budesonide Inhaler Sales Forecast by Region (2022-2027)
2.4.2 Global Budesonide Inhaler Revenue Forecast by Region (2022-2027)

3 Global Budesonide Inhaler Competitor Landscape by Players
3.1 Global Top Budesonide Inhaler Manufacturers by Sales
3.1.1 Global Budesonide Inhaler Sales by Manufacturer (2016-2021)
3.1.2 Global Budesonide Inhaler Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Budesonide Inhaler Manufacturers by Revenue
3.2.1 Key Budesonide Inhaler Manufacturers Covered: Ranking by Revenue
3.2.2 Global Budesonide Inhaler Revenue by Manufacturers (2016-2021)
3.2.3 Global Budesonide Inhaler Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Budesonide Inhaler Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Budesonide Inhaler Revenue in 2020
3.2.6 Global Budesonide Inhaler Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Budesonide Inhaler Price by Manufacturers
3.4 Global Budesonide Inhaler Manufacturing Base Distribution, Product Types
3.4.1 Budesonide Inhaler Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Budesonide Inhaler Product Type
3.4.3 Date of International Manufacturers Enter into Budesonide Inhaler Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Budesonide Inhaler Market Size by Type (2016-2021)
4.1.1 Global Budesonide Inhaler Sales by Type (2016-2021)
4.1.2 Global Budesonide Inhaler Revenue by Type (2016-2021)
4.1.3 Budesonide Inhaler Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Budesonide Inhaler Market Size Forecast by Type (2022-2027)
4.2.1 Global Budesonide Inhaler Sales Forecast by Type (2022-2027)
4.2.2 Global Budesonide Inhaler Revenue Forecast by Type (2022-2027)
4.2.3 Budesonide Inhaler Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Budesonide Inhaler Market Size by Application (2016-2021)
5.1.1 Global Budesonide Inhaler Sales by Application (2016-2021)
5.1.2 Global Budesonide Inhaler Revenue by Application (2016-2021)
5.1.3 Budesonide Inhaler Price by Application (2016-2021)
5.2 Budesonide Inhaler Market Size Forecast by Application (2022-2027)
5.2.1 Global Budesonide Inhaler Sales Forecast by Application (2022-2027)
5.2.2 Global Budesonide Inhaler Revenue Forecast by Application (2022-2027)
5.2.3 Global Budesonide Inhaler Price Forecast by Application (2022-2027)

6 Japan by Players, Type and Application
6.1 Japan Budesonide Inhaler Market Size YoY Growth 2016-2027
6.1.1 Japan Budesonide Inhaler Sales YoY Growth 2016-2027
6.1.2 Japan Budesonide Inhaler Revenue YoY Growth 2016-2027
6.1.3 Japan Budesonide Inhaler Market Share in Global Market 2016-2027
6.2 Japan Budesonide Inhaler Market Size by Players (International and Local Players)
6.2.1 Japan Top Budesonide Inhaler Players by Sales (2016-2021)
6.2.2 Japan Top Budesonide Inhaler Players by Revenue (2016-2021)
6.3 Japan Budesonide Inhaler Historic Market Review by Type (2016-2021)
6.3.1 Japan Budesonide Inhaler Sales Market Share by Type (2016-2021)
6.3.2 Japan Budesonide Inhaler Revenue Market Share by Type (2016-2021)
6.3.3 Japan Budesonide Inhaler Price by Type (2016-2021)
6.4 Japan Budesonide Inhaler Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Budesonide Inhaler Sales Forecast by Type (2022-2027)
6.4.2 Japan Budesonide Inhaler Revenue Forecast by Type (2022-2027)
6.4.3 Japan Budesonide Inhaler Price Forecast by Type (2022-2027)
6.5 Japan Budesonide Inhaler Historic Market Review by Application (2016-2021)
6.5.1 Japan Budesonide Inhaler Sales Market Share by Application (2016-2021)
6.5.2 Japan Budesonide Inhaler Revenue Market Share by Application (2016-2021)
6.5.3 Japan Budesonide Inhaler Price by Application (2016-2021)
6.6 Japan Budesonide Inhaler Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Budesonide Inhaler Sales Forecast by Application (2022-2027)
6.6.2 Japan Budesonide Inhaler Revenue Forecast by Application (2022-2027)
6.6.3 Japan Budesonide Inhaler Price Forecast by Application (2022-2027)

7 North America
7.1 North America Budesonide Inhaler Market Size YoY Growth 2016-2027
7.2 North America Budesonide Inhaler Market Facts & Figures by Country
7.2.1 North America Budesonide Inhaler Sales by Country (2016-2021)
7.2.2 North America Budesonide Inhaler Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Budesonide Inhaler Market Size YoY Growth 2016-2027
8.2 Asia Pacific Budesonide Inhaler Market Facts & Figures by Region
8.2.1 Asia Pacific Budesonide Inhaler Sales by Region (2016-2021)
8.2.2 Asia Pacific Budesonide Inhaler Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Budesonide Inhaler Market Size YoY Growth 2016-2027
9.2 Europe Budesonide Inhaler Market Facts & Figures by Country
9.2.1 Europe Budesonide Inhaler Sales by Country (2016-2021)
9.2.2 Europe Budesonide Inhaler Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Budesonide Inhaler Market Size YoY Growth 2016-2027
10.2 Latin America Budesonide Inhaler Market Facts & Figures by Country
10.2.1 Latin America Budesonide Inhaler Sales by Country (2016-2021)
10.2.2 Latin America Budesonide Inhaler Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Budesonide Inhaler Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Budesonide Inhaler Market Facts & Figures by Country
11.2.1 Middle East and Africa Budesonide Inhaler Sales by Country (2016-2021)
11.2.2 Middle East and Africa Budesonide Inhaler Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 AstraZeneca
12.1.1 AstraZeneca Corporation Information
12.1.2 AstraZeneca Description and Business Overview
12.1.3 AstraZeneca Budesonide Inhaler Sales, Revenue and Gross Margin (2016-2021)
12.1.4 AstraZeneca Budesonide Inhaler Products Offered
12.1.5 AstraZeneca Recent Development
12.2 Cosmo Pharmaceuticals
12.2.1 Cosmo Pharmaceuticals Corporation Information
12.2.2 Cosmo Pharmaceuticals Description and Business Overview
12.2.3 Cosmo Pharmaceuticals Budesonide Inhaler Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Cosmo Pharmaceuticals Budesonide Inhaler Products Offered
12.2.5 Cosmo Pharmaceuticals Recent Development
12.3 Teva Pharmaceutical
12.3.1 Teva Pharmaceutical Corporation Information
12.3.2 Teva Pharmaceutical Description and Business Overview
12.3.3 Teva Pharmaceutical Budesonide Inhaler Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Teva Pharmaceutical Budesonide Inhaler Products Offered
12.3.5 Teva Pharmaceutical Recent Development
12.4 Novartis
12.4.1 Novartis Corporation Information
12.4.2 Novartis Description and Business Overview
12.4.3 Novartis Budesonide Inhaler Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Novartis Budesonide Inhaler Products Offered
12.4.5 Novartis Recent Development
12.5 Mylan
12.5.1 Mylan Corporation Information
12.5.2 Mylan Description and Business Overview
12.5.3 Mylan Budesonide Inhaler Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Mylan Budesonide Inhaler Products Offered
12.5.5 Mylan Recent Development
12.6 Pfizer
12.6.1 Pfizer Corporation Information
12.6.2 Pfizer Description and Business Overview
12.6.3 Pfizer Budesonide Inhaler Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Pfizer Budesonide Inhaler Products Offered
12.6.5 Pfizer Recent Development
12.7 Dr. Falk Pharma
12.7.1 Dr. Falk Pharma Corporation Information
12.7.2 Dr. Falk Pharma Description and Business Overview
12.7.3 Dr. Falk Pharma Budesonide Inhaler Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Dr. Falk Pharma Budesonide Inhaler Products Offered
12.7.5 Dr. Falk Pharma Recent Development
12.8 Chiesi Farmaceutici
12.8.1 Chiesi Farmaceutici Corporation Information
12.8.2 Chiesi Farmaceutici Description and Business Overview
12.8.3 Chiesi Farmaceutici Budesonide Inhaler Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Chiesi Farmaceutici Budesonide Inhaler Products Offered
12.8.5 Chiesi Farmaceutici Recent Development
12.9 Orion Corporation
12.9.1 Orion Corporation Corporation Information
12.9.2 Orion Corporation Description and Business Overview
12.9.3 Orion Corporation Budesonide Inhaler Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Orion Corporation Budesonide Inhaler Products Offered
12.9.5 Orion Corporation Recent Development
12.10 Cipla Limited
12.10.1 Cipla Limited Corporation Information
12.10.2 Cipla Limited Description and Business Overview
12.10.3 Cipla Limited Budesonide Inhaler Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Cipla Limited Budesonide Inhaler Products Offered
12.10.5 Cipla Limited Recent Development
12.11 AstraZeneca
12.11.1 AstraZeneca Corporation Information
12.11.2 AstraZeneca Description and Business Overview
12.11.3 AstraZeneca Budesonide Inhaler Sales, Revenue and Gross Margin (2016-2021)
12.11.4 AstraZeneca Budesonide Inhaler Products Offered
12.11.5 AstraZeneca Recent Development
12.12 Takeda Pharmaceutical
12.12.1 Takeda Pharmaceutical Corporation Information
12.12.2 Takeda Pharmaceutical Description and Business Overview
12.12.3 Takeda Pharmaceutical Budesonide Inhaler Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Takeda Pharmaceutical Products Offered
12.12.5 Takeda Pharmaceutical Recent Development
12.13 Lupin Limited
12.13.1 Lupin Limited Corporation Information
12.13.2 Lupin Limited Description and Business Overview
12.13.3 Lupin Limited Budesonide Inhaler Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Lupin Limited Products Offered
12.13.5 Lupin Limited Recent Development
12.14 Synmosa Biopharma Corporation
12.14.1 Synmosa Biopharma Corporation Corporation Information
12.14.2 Synmosa Biopharma Corporation Description and Business Overview
12.14.3 Synmosa Biopharma Corporation Budesonide Inhaler Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Synmosa Biopharma Corporation Products Offered
12.14.5 Synmosa Biopharma Corporation Recent Development
12.15 Lunan Better Pharmaceutical
12.15.1 Lunan Better Pharmaceutical Corporation Information
12.15.2 Lunan Better Pharmaceutical Description and Business Overview
12.15.3 Lunan Better Pharmaceutical Budesonide Inhaler Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Lunan Better Pharmaceutical Products Offered
12.15.5 Lunan Better Pharmaceutical Recent Development
12.16 Shanghai Sine Pharmaceutical Laboratories
12.16.1 Shanghai Sine Pharmaceutical Laboratories Corporation Information
12.16.2 Shanghai Sine Pharmaceutical Laboratories Description and Business Overview
12.16.3 Shanghai Sine Pharmaceutical Laboratories Budesonide Inhaler Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Shanghai Sine Pharmaceutical Laboratories Products Offered
12.16.5 Shanghai Sine Pharmaceutical Laboratories Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Budesonide Inhaler Industry Trends
13.2 Budesonide Inhaler Market Drivers
13.3 Budesonide Inhaler Market Challenges
13.4 Budesonide Inhaler Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Budesonide Inhaler Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer